Form 13-F position report

PALANTIR TECHNOLOGIES INC CL A

Reported by Howard Hughes Medical Institute

PLTR CUSIP 69608A108 Manager CIK 0000810386

Reported 64,567 shares, up 33,810 (109.9%) from the prior quarter.

Reported value 236.6%; share count 109.9% vs. the prior quarter.

Added
% of reported 13F value 1.15% This manager · Q3 2026
Shares 64,567 Quarter-end amount reported
Reported value $12,077,257 Fair value at quarter end
Consecutive quarters held 6 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-06-30 60117
2025-09-30 89021
2025-12-31 87098
2026-03-31 4499134
2026-06-30 3588419
2026-09-30 12077257

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for PALANTIR TECHNOLOGIES INC CL A held by Howard Hughes Medical Institute.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 64,567 +33,810 (109.9%) 1.15% $12,077,257 2026-11-16
Q2 2026 Unchanged 30,757 0 (0.0%) 0.81% $3,588,419 2026-08-14
Q1 2026 Added 30,757 +30,267 (6176.9%) 1.08% $4,499,134 2026-05-15
Q4 2025 Added 490 +2 (0.4%) 0.05% $87,098 2026-02-17
Q3 2025 Added 488 +47 (10.7%) 0.05% $89,021 2025-11-14
Q2 2025 New 441 +441 (0.0%) 0.02% $60,117 2025-08-14

Who else reported the position

3341 managers reported PALANTIR TECHNOLOGIES INC CL A for Q3 2026.

Managers reporting PALANTIR TECHNOLOGIES INC CL A in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 189,782,108 -35,585 0.52% $35,498,743,233 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 146,760,154 +622,640 0.58% $27,451,486,806 3 qtrs
STATE STREET CORPORATION Reduced 104,326,819 -163,649 0.57% $19,514,331,494 24 qtrs
Invesco Ltd Reduced 70,174,299 -264,218 1.03% $13,126,102,638 24 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 56,111,466 +776,498 0.54% $10,467,531,889 24 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 50,500,594 +223,785 0.43% $9,446,136,108 3 qtrs
FMR LLC Added 48,981,219 +26,412,610 0.4% $9,161,937,007 24 qtrs
JPMorgan Chase & Co Added 40,457,805 +10,962,831 0.41% $7,564,396,359 25 qtrs
MORGAN STANLEY Added 34,454,271 +432,984 0.33% $6,444,671,719 25 qtrs
PRICE T ROWE ASSOCIATES INC MD Added 22,203,197 +14,483,094 0.42% $4,153,109,000 25 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
CL A

Voting authority reported

Sole
64,567
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.